Hydroxychloroquine and Indapamide in SPMS

Clinical trial NCT05013463 · UNKNOWN

Trial details

NCT number: NCT05013463
Sponsor: University of Calgary
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Secondary Progressive

Start date: 2021-10-01
Primary completion: 2023-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.